Evidence map›Paper›PMID 37570689›Full record

ReviewMolecules (Basel, Switzerland)2023

Preventing the Galvanic Replacement Reaction toward Unconventional Bimetallic Core-Shell Nanostructures.

Kai Liu, Zhun Qiao, Chuanbo Gao

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. SERS-Based Nano- and Microsystems Toward Biomedical Applications.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kai LiuFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710054, China.ORCID 0000-0001-5552-5013
Zhun QiaoFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710054, China.
Chuanbo GaoFrontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710054, China.ORCID 0000-0003-3429-3473

Funding

China Postdoctoral Science Foundation 2019TQ0249Key Research and Development Program of Shaanxi Province 2021GXLH-Z-022National Natural Science Foundation of China 22071191Natural Science Basic Research Plan in Shaanxi Province 2022JQ-100
6 · The paper itself

Abstract

A bimetallic core-shell nanostructure is a versatile platform for achieving intriguing optical and catalytic properties. For a long time, this core-shell nanostructure has been limited to ones with noble metal cores. Otherwise, a galvanic replacement reaction easily occurs, leading to hollow nanostructures or completely disintegrated ones. In the past few years, great efforts have been devoted to preventing the galvanic replacement reaction, thus creating an unconventional class of core-shell nanostructures, each containing a less-stable-metal core and a noble metal shell. These new nanostructures have been demonstrated to show unique optical and catalytic properties. In this work, we first briefly summarize the strategies for synthesizing this type of unconventional core-shell nanostructures, such as the delicately designed thermodynamic control and kinetic control methods. Then, we discuss the effects of the core-shell nanostructure on the stabilization of the core nanocrystals and the emerging optical and catalytic properties. The use of the nanostructure for creating hollow/porous nanostructures is also discussed. At the end of this review, we discuss the remaining challenges associated with this unique core-shell nanostructure and provide our perspectives on the future development of the field.

Indexed as

catalytic propertycore–shell nanostructuregalvanic replacement preventionnoble metaloptical property

Identifiers

PMID37570689
PMCPMC10419990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.